Skip to main content

Rockefeller Capital Management L.P.

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1739439 NEW YORK, NY

Position in REGN

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$22,035,691
+$1,154,294 QoQ
Shares Held
28,520
+5.4% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 96.66549789621318.ToString("F0")% Shared 0.ToString("F0")% None 3.334502103786816.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Rockefeller Capital Management L.P. holds $285,796,172 across 243 Biotechnology names. REGN ranks #5 (7.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 REGN
Regeneron Pharmaceuticals, Inc.
This page
28,520 $22,035,691

All Filings in REGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $22,035,691 28,520
2025-12-31 $20,881,397 27,053
2025-09-30 $14,530,180 25,842
2025-06-30 $15,550,500 29,620
2025-03-31 $42,879,019 67,608
2024-12-31 $67,488,992 94,744
2024-09-30 $103,025,723 98,004
2024-06-30 $104,157,071 99,100
2024-03-31 $100,773,663 104,701
2023-12-31 $92,757,083 105,611
2023-09-30 $85,596,890 104,011
2023-06-30 $56,543,348 78,692
2023-03-31 $62,002,394 75,459
2022-12-31 $54,462,393 75,486
2022-09-30 $55,736,470 80,910
2022-06-30 $48,324,285 81,749
2022-03-31 $64,011,588 91,652
2021-12-31 $54,411,762 86,160
2021-09-30 $52,852,788 87,334
2021-06-30 $105,982,964 189,750
2021-03-31 $60,208,008 127,252
2020-12-31 $52,475,890 108,621
2020-09-30 $58,541,791 104,580
2020-06-30 $82,196,445 131,799
2020-03-31 $65,679,398 134,509